Literature DB >> 6286144

An alteration in the phosphorylation of vimentin-type intermediate filaments is associated with mitosis in cultured mammalian cells.

R M Evans, L M Fink.   

Abstract

Analysis of cultured Chinese hamster ovary (CHO) cells has shown that vimentin exists primarily as two 57,000 dalton isoelectric variants, a nonphosphorylated form and a slightly more acidic phosphorylated form. Similar analyses of CHO cells that were treated with colcemid show the presence of at least two to three additional, more acidic, phosphorylated vimentin isoelectric variants. An increasing 32P-specific activity of these variants suggests that this alteration involves increased phosphorylation. Analysis of 32P-labeled vimentin from colcemid-treated cells indicates that the amount of the additional phosphorylated variants correlates with the accumulation of cells in mitosis. CHO cells enriched in mitotic cells without antimitotic drugs demonstrate the same alteration in the isoelectric focusing pattern of phosphorylated vimentin. When mitotic cells are replated, the amount of additional phosphorylated variants is reduced within 30 min. The data suggest that an alteration in phosphorylated vimentin is temporally related to the alteration in the organization of intermediate filaments in mitotic cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6286144     DOI: 10.1016/0092-8674(82)90088-5

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  29 in total

1.  Nestin promotes the phosphorylation-dependent disassembly of vimentin intermediate filaments during mitosis.

Authors:  Ying-Hao Chou; Satya Khuon; Harald Herrmann; Robert D Goldman
Journal:  Mol Biol Cell       Date:  2003-04       Impact factor: 4.138

2.  Cell cycle-dependent changes in the organization of an intermediate filament-associated protein: correlation with phosphorylation by p34cdc2.

Authors:  O Skalli; Y H Chou; R D Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

3.  Phosphorylation and disassembly of intermediate filaments in mitotic cells.

Authors:  Y H Chou; E Rosevear; R D Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

4.  Head and rod 1 interactions in vimentin: identification of contact sites, structure, and changes with phosphorylation using site-directed spin labeling and electron paramagnetic resonance.

Authors:  Atya Aziz; John F Hess; Madhu S Budamagunta; Paul G FitzGerald; John C Voss
Journal:  J Biol Chem       Date:  2008-12-31       Impact factor: 5.157

5.  Intermediate filament expression and lifespan potential in human somatic cell hybrids.

Authors:  C L Bunn; F A White; W M O'Guin; R H Sawyer; L W Knapp
Journal:  In Vitro Cell Dev Biol       Date:  1985-12

6.  Effects of phosphorylation of the neurofilament L protein on filamentous structures.

Authors:  S Hisanaga; Y Gonda; M Inagaki; A Ikai; N Hirokawa
Journal:  Cell Regul       Date:  1990-01

7.  Identification of phosphorylation-induced changes in vimentin intermediate filaments by site-directed spin labeling and electron paramagnetic resonance.

Authors:  Josh T Pittenger; John F Hess; Madhu S Budamagunta; John C Voss; Paul G Fitzgerald
Journal:  Biochemistry       Date:  2008-09-20       Impact factor: 3.162

Review 8.  Intermediate filaments as dynamic structures.

Authors:  M W Klymkowsky
Journal:  Cancer Metastasis Rev       Date:  1996-12       Impact factor: 9.264

9.  Cellular vimentin regulates construction of dengue virus replication complexes through interaction with NS4A protein.

Authors:  Catherine Su Hui Teo; Justin Jang Hann Chu
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

10.  Mammalian growth-associated H1 histone kinase: a homolog of cdc2+/CDC28 protein kinases controlling mitotic entry in yeast and frog cells.

Authors:  T A Langan; J Gautier; M Lohka; R Hollingsworth; S Moreno; P Nurse; J Maller; R A Sclafani
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.